C3897345_NCI_CareLex | Knowledge4COVID-19

Property	Value
?:definition	A written confirmation that the investigational product (IP) has been either manufactured of materials of non-animal origin or, if using materials of animal origin, that all measures have been taken to minimize the risk of spreading transmissible spongiform encephalopathy (TSE) via medicinal products. May be included in Clinical Trial Applications.
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C3897345>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_CareLex>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C3897345_NCI_CareLex>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C3897345_NCI_CareLex>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all